Stock Fundamentals

Company Information

Company Name
Sellas Life Sciences Group Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US81642T2096
CIK: 0001390478
CUSIP: 74978T109
Currency: USD
Full Time Employees: 13
Phone: 646 200 5278
Fiscal Year End: December
IPO Date: Dec 29, 2017
Description:

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.

Address:

7 Times Square, New York, NY, United States, 10036

Directors & Officers

Name Title Year Born
Dr. Angelos M. Stergiou M.D., ScD h.c. Founder, President, CEO & Director 1976
Mr. John Thomas Burns CPA Senior VP & CFO 1985
Dr. Dragan Cicic M.D., MBA Senior VP & Chief Development Officer 1963
Ms. Stacy E. Yeung VP, General Counsel & Corporate Secretary NA
Mr. Andrew Elnatan Senior VP of Regulatory Affairs, CMC & Quality NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 19, 2025 Katherine Bach Kalin N/A Purchase 63.40K $1.59 $100.81K
Jun 12, 2025 Nostrand Robert L Van N/A Purchase 10.00K $1.48 $14.80K
May 30, 2025 Jane Wasman N/A Purchase 20.00K $1.69 $33.80K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 12.20M Mar 31, 2026 6.61% $0.00 61.76%
Vanguard Group Inc 8.47M Dec 31, 2025 4.59% $0.00 23.79%
State Street Corp 8.40M Mar 31, 2026 4.55% $0.00 283.72%
Geode Capital Management, LLC 3.91M Mar 31, 2026 2.12% $0.00 27.14%
Marshall Wace Asset Management Ltd 2.04M Mar 31, 2026 1.10% $0.01 51.95%
JONES FINANCIAL COMPANIES LLLP 1.68M Mar 31, 2026 0.91% $0.00 290.24%
Morgan Stanley - Brokerage Accounts 1.34M Mar 31, 2026 0.72% $0.00 49.99%
Northern Trust Corp 1.28M Mar 31, 2026 0.69% $0.00 37.09%
Dagco Inc 1.03M Mar 31, 2026 0.56% $0.94 78.13%
UBS Group AG 745.42K Mar 31, 2026 0.40% $0.00 1,429.79%
Amvescap Plc. 698.08K Mar 31, 2026 0.38% $0.00 1,209.89%
Nuveen, LLC 670.97K Mar 31, 2026 0.36% $0.00 -34.47%
Bank of America Corp 641.68K Mar 31, 2026 0.35% $0.00 535.74%
The Goldman Sachs Group Inc 555.91K Mar 31, 2026 0.30% $0.00 35.04%
Charles Schwab Investment Management Inc 480.60K Mar 31, 2026 0.26% $0.00 17.68%
Bank of New York Mellon Corp 478.37K Mar 31, 2026 0.26% $0.00 86.56%
Two Sigma Investments LLC 403.17K Mar 31, 2026 0.22% $0.00 -62.75%
Susquehanna International Group, LLP 397.06K Mar 31, 2026 0.22% $0.00 13.52%
Everhart Financial Group, Inc. 364.40K Mar 31, 2026 0.20% $0.13 -21.84%
Opus Capital Group LLC 346.45K Mar 31, 2026 0.19% $0.16 9.26%

Shares Statistics

Shares Outstanding: 196.63M
Shares Float: 185.23M
% Insiders: 42.90%
% Institutions: 2,921.50%
Short % Float: 30.81%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 5.44M 2.95% ▲ 9.56% Apr 30, 2026
2 State Street® SPDR® S&P® Biotech ETF 5.24M 2.84% ▼ 0.70% Apr 30, 2026
3 iShares Russell 2000 ETF 4.02M 2.18% ▲ 0.85% Apr 30, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 1.92M 1.04% ▲ 1.11% Apr 30, 2026
5 iShares Russell 2000 Growth ETF 1.40M 0.76% ▲ 0.26% Apr 30, 2026
6 Fidelity Small Cap Index 1.21M 0.66% ▲ 0.97% Feb 28, 2026
7 State St Russell Sm/Mid Cp® Indx SL Cl I 1.02M 0.55% ▲ 0.00% Apr 30, 2026
8 Vanguard Russell 2000 ETF 869.78K 0.47% ▲ 2.80% Apr 30, 2026
9 Russell 2000 Equity Index Fund B 800.77K 0.43% ▲ 29.43% Dec 31, 2025
10 Fidelity Extended Market Index 743.11K 0.40% ▼ 0.43% Mar 31, 2026

Valuation Metrics

Enterprise Value: $1.58B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $1.64B
Book Value: $0.59
Earnings/Share: $-0.23
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -25.45%
ROE (TTM): -43.59%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -82.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 10.72x 0.01x 0.10x N/A -0.02x
2024-12-31 1.72x 0.06x 0.51x N/A 0.86x
2023-12-31 0.23x -0.06x 2.28x N/A 0.84x
2022-12-31 1.14x 0.08x 0.77x -64.64x -0.01x
2021-12-31 4.63x 0.01x 0.23x -5.80x -0.01x
2020-12-31 2.99x 0.01x 0.39x -43.54x 0.01x
2019-12-31 1.56x 0.04x 0.63x -169.84x 0.32x
2018-12-31 0.98x 0.00x 0.69x -118.76x 0.00x
2017-12-31 0.53x 5.31x 0.94x -34.01x -0.48x
2016-12-31 1.23x 0.77x 0.56x -4.56x -1.38x
2015-12-31 0.94x 1.16x 0.84x -45.03x -0.42x
2014-12-31 1.07x 0.23x 0.54x -32.98x -0.23x
2013-12-31 0.86x 1.68x 0.93x -41.93x 1.30x
2012-12-31 2.27x 0.00x 0.50x -642.39x 0.00x
2011-12-31 1.05x 0.05x 0.67x N/A -0.05x
2010-12-31 1.40x 0.04x 0.67x -3,325.00x -0.01x
2009-12-31 1.06x 0.14x 0.88x -3,504.00x -0.01x
2008-12-31 7.16x 0.00x 0.13x N/A 0.00x
2007-12-31 8.86x 0.00x 0.11x N/A 0.00x
2006-12-31 N/A 0.00x 0.00x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SLS.US!